Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes

Biochemistry
T WieprechtM Bienert

Abstract

The magainins are antibacterial peptides from the skin of Xenopus laevis. They show a broad range of activity against prokaryotic cells but lyse eukaryotic cells poorly. To elucidate the influence of peptide hydrophobicity on membrane activity and selectivity, we designed and synthesized analogs of magainin 2 amide with slightly varying hydrophobicities but retained hydrophobic moment, peptide charge, and angle subtended by the hydrophilic helix region. Circular dichroism investigations of the peptides revealed that all peptides investigated adopt an alpha-helical conformation when bound to phospholipid vesicles. Dye-releasing experiments from vesicles of phosphatidylglycerol (PG) showed that the membrane-permeabilizing activity of the analogs is not influenced by peptide hydrophobicity. In contrast, the permeability-enhancing activity on vesicles bearing high amounts of phosphatidylcholine (PC) increases drastically with enhanced peptide hydrophobicity, resulting in a reduced selectivity of more hydrophobic analogs for negatively charged membranes. Likewise, the peptide affinity to PC-rich membranes increases in the order of hydrophobicity. Correlation of peptide binding and membrane permeabilization of PC/PG (3:1) vesicles re...Continue Reading

References

Aug 3, 1992·European Journal of Pharmacology·R A CrucianiE F Stanley
Jan 1, 1984·Annual Review of Biochemistry·D Eisenberg
Aug 2, 1996·Journal of Medicinal Chemistry·M M JavadpourM L McLaughlin

❮ Previous
Next ❯

Citations

Aug 10, 2000·Biopolymers·A TossiA Giangaspero
Oct 12, 2010·Applied Microbiology and Biotechnology·Thangamani RajeshParamasamy Gunasekaran
Jun 25, 2009·Journal of Biosciences·Chandrasekaran Sivakamasundari, Ramakrishnan Nagaraj
Nov 7, 1998·Biochimica Et Biophysica Acta·K Matsuzaki
Oct 31, 1998·Biochimica Et Biophysica Acta·R GennaroM Zanetti
Sep 29, 2011·Biochemistry·Aurélien LorinMichèle Auger
Oct 1, 2011·Biomacromolecules·Jing HuJian R Lu
Sep 6, 2000·Letters in Applied Microbiology·W A PowellC A Maynard
Feb 26, 2000·European Journal of Biochemistry·M L MangoniM Simmaco
Oct 20, 2010·Proceedings of the National Academy of Sciences of the United States of America·Manu S MannoorMichael C McAlpine
Aug 16, 2013·The Journal of Antimicrobial Chemotherapy·Hyun KimJu Hyun Cho
Apr 9, 1999·The Journal of Peptide Research : Official Journal of the American Peptide Society·J E OhK H Lee
Dec 13, 2006·Antimicrobial Agents and Chemotherapy·Yuxin ChenRobert S Hodges
Jul 3, 2004·Reproduction : the Official Journal of the Society for the Study of Fertility·K V R ReddyR D Yedery
Jul 6, 2000·Bioscience, Biotechnology, and Biochemistry·S MachidaY Yu
Sep 23, 2014·BioMed Research International·Thomas EbenhanMike Machaba Sathekge
Sep 29, 2001·The Journal of Peptide Research : Official Journal of the American Peptide Society·A C RinaldiM Simmaco
Oct 20, 2009·FEBS Letters·Guillaume Drin, Bruno Antonny
Sep 20, 2015·Amino Acids·Weizhong LiAnshan Shan
Aug 10, 2011·Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology·Stephen S WanyonyiKevin R Nicholas
Feb 27, 2010·Journal of Colloid and Interface Science·Alexander F Chu-KungMatthew Tirrell
Oct 28, 2009·Toxicon : Official Journal of the International Society on Toxinology·Ji Hyeong Baek, Si Hyeock Lee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.